Clinical trials
Phase 2/3 Acquired Immunodeficiency Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 3 |
| Unknown status | 3 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 4 |
| Institute for Human Genetics and Biochemistry | 2 |
| University of Hawaii | 2 |
| University of Pennsylvania | 2 |
| AbbVie | 1 |
| Children's Hospital of Philadelphia | 1 |
| CytoDyn, Inc. | 1 |
| David Boulware | 1 |
| Education Development Center, Inc. | 1 |
| French National Agency for Research on AIDS and Viral Hepatitis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 29 |
| HIV Infections | 12 |
| Tuberculosis | 4 |
| Hepatitis C | 2 |
| Opioid-Related Disorders | 2 |
| Sexually Transmitted Diseases | 2 |
| AIDS Dementia Complex | 1 |
| Communicable Diseases | 1 |
| Cytomegalovirus Infections | 1 |
| Diarrhea | 1 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.